S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

LGND Ligand Pharmaceuticals Incorporated

109.19

-5.06 (-4.43%)

28 Dec 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals Incorporated News

Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance
Wednesday 11 December 2024 (3 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 7 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 28 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Ligand to Present at Stifel 2024 Healthcare Conference
Friday 15 November 2024 (1 month ago) • Business Wire

Form 144 - Report of proposed sale of securities
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Thursday 17 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 26 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 25 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 25 September 2024 (3 months ago) • Edgar (US Regulatory)

More Ligand Pharmaceuticals Incorporated News Articles

Sterling vs AUD

Australia And New Zealan...

Australian SE All Ordina...

Newcrest Mining

Verizon Communications

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions